Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-11-13
1986-09-02
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548341, A61K 31415
Patent
active
046096701
ABSTRACT:
Imidazolium salts are effective in lowering blood glucose levels in mammals following administration.
REFERENCES:
patent: 3852301 (1974-12-01), Haugwitz et al.
patent: 4017631 (1977-04-01), Janssen et al.
patent: 4243670 (1981-01-01), Regel et al.
patent: 4251540 (1981-02-01), Regel et al.
Boekelheide, V. et al., J. Am. Chem. Soc., 90, 14, 3830, (1968).
Nardi, D. et al., J. Med. Chem., 24, 727-731, (1981).
Schutze, D. et al., Justus Liebigs Ann. Chem. 765, 29-33, (1972).
Jones, J. et al., Can. J. Chem., 49(2), 325-332, (1971).
Lown, J. et al., Can. J. Chem., 53(24), 3782-3790, (1975).
Tsuge, O. et al., Bull. Chem. Soc. Jpn., 56, 2073-2076, (1983).
Rudenko, A. et al., J. Prakt. Chem. 325(4), 627-641, (1983).
Dominianni Samuel J.
Yen Terence T.
Barclay Bruce J.
Eli Lilly and Company
Schwartz Richard A.
Whale Arthur R.
LandOfFree
Imidazolium hypoglycemic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolium hypoglycemic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolium hypoglycemic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097848